Fisher & Paykel Healthcare Corporation Limited

Informe acción NZSE:FPH

Capitalización de mercado: NZ$16.4b

Fisher & Paykel Healthcare Dirección

Dirección controles de criterios 4/4

El CEO de Fisher & Paykel Healthcare's es Lewis Gradon , nombrado en Apr 2016, tiene una permanencia de 8.08 años. compensación anual total es NZ$3.67M, compuesta por 46.5% salario y 53.5% primas, incluidas acciones y opciones de la empresa. posee directamente un 0.099% de las acciones de la empresa, por valor de NZ$16.47M. La antigüedad media del equipo directivo y de la junta directiva es de 3 años y 6.2 años, respectivamente.

Información clave

Lewis Gradon

Chief Executive Officer (CEO)

NZ$3.7m

Compensación total

Porcentaje del salario del CEO46.5%
Permanencia del CEO8.1yrs
Participación del CEO0.1%
Permanencia media de la dirección3yrs
Promedio de permanencia en la Junta Directiva6.2yrs

Actualizaciones recientes de la dirección

Recent updates

Is Fisher & Paykel Healthcare (NZSE:FPH) Using Too Much Debt?

Mar 27
Is Fisher & Paykel Healthcare (NZSE:FPH) Using Too Much Debt?

Be Wary Of Fisher & Paykel Healthcare (NZSE:FPH) And Its Returns On Capital

Feb 22
Be Wary Of Fisher & Paykel Healthcare (NZSE:FPH) And Its Returns On Capital

Fisher & Paykel Healthcare Corporation Limited's (NZSE:FPH) Business Is Yet to Catch Up With Its Share Price

Feb 05
Fisher & Paykel Healthcare Corporation Limited's (NZSE:FPH) Business Is Yet to Catch Up With Its Share Price

Fisher & Paykel Healthcare Corporation Limited (NZSE:FPH) Shares Could Be 31% Above Their Intrinsic Value Estimate

Jan 03
Fisher & Paykel Healthcare Corporation Limited (NZSE:FPH) Shares Could Be 31% Above Their Intrinsic Value Estimate

We Think Fisher & Paykel Healthcare (NZSE:FPH) Can Stay On Top Of Its Debt

Nov 30
We Think Fisher & Paykel Healthcare (NZSE:FPH) Can Stay On Top Of Its Debt

Fisher & Paykel Healthcare (NZSE:FPH) Could Be Struggling To Allocate Capital

Nov 12
Fisher & Paykel Healthcare (NZSE:FPH) Could Be Struggling To Allocate Capital

Estimating The Fair Value Of Fisher & Paykel Healthcare Corporation Limited (NZSE:FPH)

Aug 28
Estimating The Fair Value Of Fisher & Paykel Healthcare Corporation Limited (NZSE:FPH)

Be Wary Of Fisher & Paykel Healthcare (NZSE:FPH) And Its Returns On Capital

Aug 10
Be Wary Of Fisher & Paykel Healthcare (NZSE:FPH) And Its Returns On Capital

Here's Why Fisher & Paykel Healthcare (NZSE:FPH) Can Manage Its Debt Responsibly

Jul 02
Here's Why Fisher & Paykel Healthcare (NZSE:FPH) Can Manage Its Debt Responsibly

Be Wary Of Fisher & Paykel Healthcare (NZSE:FPH) And Its Returns On Capital

May 01
Be Wary Of Fisher & Paykel Healthcare (NZSE:FPH) And Its Returns On Capital

Returns On Capital Signal Tricky Times Ahead For Fisher & Paykel Healthcare (NZSE:FPH)

Jan 23
Returns On Capital Signal Tricky Times Ahead For Fisher & Paykel Healthcare (NZSE:FPH)

Does Fisher & Paykel Healthcare (NZSE:FPH) Have A Healthy Balance Sheet?

Dec 27
Does Fisher & Paykel Healthcare (NZSE:FPH) Have A Healthy Balance Sheet?

Calculating The Fair Value Of Fisher & Paykel Healthcare Corporation Limited (NZSE:FPH)

Oct 28
Calculating The Fair Value Of Fisher & Paykel Healthcare Corporation Limited (NZSE:FPH)

Shareholders Are Optimistic That Fisher & Paykel Healthcare (NZSE:FPH) Will Multiply In Value

Oct 13
Shareholders Are Optimistic That Fisher & Paykel Healthcare (NZSE:FPH) Will Multiply In Value

Fisher & Paykel Healthcare (NZSE:FPH) Has A Pretty Healthy Balance Sheet

Sep 28
Fisher & Paykel Healthcare (NZSE:FPH) Has A Pretty Healthy Balance Sheet

Calculating The Fair Value Of Fisher & Paykel Healthcare Corporation Limited (NZSE:FPH)

Jul 24
Calculating The Fair Value Of Fisher & Paykel Healthcare Corporation Limited (NZSE:FPH)

A Look Into Fisher & Paykel Healthcare's (NZSE:FPH) Impressive Returns On Capital

Jul 10
A Look Into Fisher & Paykel Healthcare's (NZSE:FPH) Impressive Returns On Capital

Fisher & Paykel Healthcare (NZSE:FPH) Seems To Use Debt Quite Sensibly

Jun 12
Fisher & Paykel Healthcare (NZSE:FPH) Seems To Use Debt Quite Sensibly

A Look At The Fair Value Of Fisher & Paykel Healthcare Corporation Limited (NZSE:FPH)

Apr 17
A Look At The Fair Value Of Fisher & Paykel Healthcare Corporation Limited (NZSE:FPH)

Fisher & Paykel Healthcare (NZSE:FPH) Could Become A Multi-Bagger

Apr 04
Fisher & Paykel Healthcare (NZSE:FPH) Could Become A Multi-Bagger

Does Fisher & Paykel Healthcare (NZSE:FPH) Have A Healthy Balance Sheet?

Mar 06
Does Fisher & Paykel Healthcare (NZSE:FPH) Have A Healthy Balance Sheet?

With EPS Growth And More, Fisher & Paykel Healthcare (NZSE:FPH) Is Interesting

Jan 22
With EPS Growth And More, Fisher & Paykel Healthcare (NZSE:FPH) Is Interesting

Why The 41% Return On Capital At Fisher & Paykel Healthcare (NZSE:FPH) Should Have Your Attention

Dec 26
Why The 41% Return On Capital At Fisher & Paykel Healthcare (NZSE:FPH) Should Have Your Attention

Is Fisher & Paykel Healthcare (NZSE:FPH) A Risky Investment?

Dec 05
Is Fisher & Paykel Healthcare (NZSE:FPH) A Risky Investment?

This Is The Reason Why We Think Fisher & Paykel Healthcare Corporation Limited's (NZSE:FPH) CEO Deserves A Bump Up To Their Compensation

Aug 11
This Is The Reason Why We Think Fisher & Paykel Healthcare Corporation Limited's (NZSE:FPH) CEO Deserves A Bump Up To Their Compensation

Is Fisher & Paykel Healthcare Corporation Limited (NZSE:FPH) Worth NZ$31.6 Based On Its Intrinsic Value?

Aug 01
Is Fisher & Paykel Healthcare Corporation Limited (NZSE:FPH) Worth NZ$31.6 Based On Its Intrinsic Value?

Do Fisher & Paykel Healthcare's (NZSE:FPH) Earnings Warrant Your Attention?

Jul 07
Do Fisher & Paykel Healthcare's (NZSE:FPH) Earnings Warrant Your Attention?

Is Fisher & Paykel Healthcare (NZSE:FPH) A Risky Investment?

Jun 24
Is Fisher & Paykel Healthcare (NZSE:FPH) A Risky Investment?

A Look Into Fisher & Paykel Healthcare's (NZSE:FPH) Impressive Returns On Capital

May 01
A Look Into Fisher & Paykel Healthcare's (NZSE:FPH) Impressive Returns On Capital

Here's Why We Think Fisher & Paykel Healthcare (NZSE:FPH) Is Well Worth Watching

Mar 28
Here's Why We Think Fisher & Paykel Healthcare (NZSE:FPH) Is Well Worth Watching

Is Fisher & Paykel Healthcare (NZSE:FPH) Using Too Much Debt?

Mar 16
Is Fisher & Paykel Healthcare (NZSE:FPH) Using Too Much Debt?

Have Insiders Been Selling Fisher & Paykel Healthcare Corporation Limited (NZSE:FPH) Shares?

Mar 04
Have Insiders Been Selling Fisher & Paykel Healthcare Corporation Limited (NZSE:FPH) Shares?

How Much Is Fisher & Paykel Healthcare's (NZSE:FPH) CEO Getting Paid?

Feb 20
How Much Is Fisher & Paykel Healthcare's (NZSE:FPH) CEO Getting Paid?

Is Weakness In Fisher & Paykel Healthcare Corporation Limited (NZSE:FPH) Stock A Sign That The Market Could be Wrong Given Its Strong Financial Prospects?

Feb 05
Is Weakness In Fisher & Paykel Healthcare Corporation Limited (NZSE:FPH) Stock A Sign That The Market Could be Wrong Given Its Strong Financial Prospects?

Are Investors Overlooking Returns On Capital At Fisher & Paykel Healthcare (NZSE:FPH)?

Jan 25
Are Investors Overlooking Returns On Capital At Fisher & Paykel Healthcare (NZSE:FPH)?

Did You Participate In Any Of Fisher & Paykel Healthcare's (NZSE:FPH) Incredible 325% Return?

Jan 14
Did You Participate In Any Of Fisher & Paykel Healthcare's (NZSE:FPH) Incredible 325% Return?

Here's What Fisher & Paykel Healthcare Corporation Limited's (NZSE:FPH) Shareholder Ownership Structure Looks Like

Jan 03
Here's What Fisher & Paykel Healthcare Corporation Limited's (NZSE:FPH) Shareholder Ownership Structure Looks Like

Should You Be Adding Fisher & Paykel Healthcare (NZSE:FPH) To Your Watchlist Today?

Dec 24
Should You Be Adding Fisher & Paykel Healthcare (NZSE:FPH) To Your Watchlist Today?

Análisis de compensación del CEO

¿Cómo ha cambiado la remuneración de Lewis Gradon en comparación con los beneficios de Fisher & Paykel Healthcare?
FechaCompensación totalSalarioIngresos de la empresa
Sep 30 2023n/an/a

NZ$262m

Jun 30 2023n/an/a

NZ$256m

Mar 31 2023NZ$4mNZ$2m

NZ$250m

Dec 31 2022n/an/a

NZ$251m

Sep 30 2022n/an/a

NZ$251m

Jun 30 2022n/an/a

NZ$314m

Mar 31 2022NZ$4mNZ$2m

NZ$377m

Dec 31 2021n/an/a

NZ$449m

Sep 30 2021n/an/a

NZ$521m

Jun 30 2021n/an/a

NZ$522m

Mar 31 2021NZ$4mNZ$2m

NZ$524m

Dec 31 2020n/an/a

NZ$458m

Sep 30 2020n/an/a

NZ$392m

Jun 30 2020n/an/a

NZ$339m

Mar 31 2020NZ$3mNZ$1m

NZ$287m

Dec 31 2019n/an/a

NZ$260m

Sep 30 2019n/an/a

NZ$233m

Jun 30 2019n/an/a

NZ$221m

Mar 31 2019NZ$3mNZ$1m

NZ$209m

Dec 31 2018n/an/a

NZ$208m

Sep 30 2018n/an/a

NZ$206m

Jun 30 2018n/an/a

NZ$198m

Mar 31 2018NZ$2mNZ$993k

NZ$190m

Compensación vs. Mercado: La compensación total de Lewis($USD2.19M) está por debajo de la media de empresas de tamaño similar en el mercado NZ ($USD4.04M).

Compensación vs. Ingresos: La compensación de Lewis ha sido consistente con los resultados de la empresa en el último año.

CEO

Lewis Gradon (62 yo)

8.1yrs

Permanencia

NZ$3,672,241

Compensación

Mr. Lewis G. Gradon has been the Chief Executive Officer, Managing Director & Executive Director at Fisher & Paykel Healthcare Corporation Limited since April 1, 2016. He served as the Senior Vice Presiden...

Equipo directivo

NombrePosiciónPermanenciaCompensaciónPropiedad
Lewis Gradon
MD, CEO & Executive Director8.1yrsNZ$3.67m0.099%
NZ$ 16.3m
Lyndal York
Chief Financial Officer5.2yrssin datos0.000010%
NZ$ 1.6k
Andy Niccol
COO & GM of Respiratory Humidificationless than a yearsin datossin datos
Andrew Somervell
Vice President of Products & Technology8.1yrssin datos0.018%
NZ$ 2.9m
Hayden Brown
Head of Capital Markets & Investor Relationsno datasin datossin datos
Raelene Leonard
Company Secretary & General Counselless than a yearsin datossin datos
Daniel Adolph
Senior Communications & Investor Relations Managerno datasin datossin datos
Justin Callahan
VP of Sales & Marketing and President of North America & Europeless than a yearsin datossin datos
Nicola Talbot
Vice President of Human Resources3.6yrssin datossin datos
Jonathan Rhodes
Vice President of Supply Chain2.3yrssin datossin datos
Marcus Driller
Vice President of Corporateno datasin datossin datos
Chris Crone
General Manager of Airvo Optiflowno datasin datossin datos

3.0yrs

Permanencia media

Equipo directivo experimentado: El equipo directivo de FPH se considera experimentado (2.9 años antigüedad media).

Miembros de la Junta

NombrePosiciónPermanenciaCompensaciónPropiedad
Lewis Gradon
MD, CEO & Executive Director8.1yrsNZ$3.67m0.099%
NZ$ 16.3m
Michael Daniell
Non-Executive Director22.5yrsNZ$160.90k0.15%
NZ$ 25.3m
Neville Mitchell
Independent Non-Executive Director5.5yrsNZ$212.81k0.0013%
NZ$ 206.8k
Scott St John
Independent Chairman8.6yrsNZ$284.97k0.0039%
NZ$ 633.6k
Lisa E. McIntyre
Independent Non-Executive Director2.6yrsNZ$181.84k0.0023%
NZ$ 377.6k
Elspeth MacRae
Member of EcoDesign Advisory Boardno datasin datossin datos
Graham McLean
Non-Executive Independent Directorless than a yearsin datossin datos
Philippa Greenwood
Independent Non-Executive Director6.9yrsNZ$165.21k0.00065%
NZ$ 106.7k
Cather Simpson
Independent Non-Executive Director1.9yrsNZ$129.19k0.00021%
NZ$ 34.5k
David Trubridge
Member of EcoDesign Advisory Boardno datasin datossin datos
David Galler
Member of EcoDesign Advisory Boardno datasin datossin datos
Ann Smith
Member of EcoDesign Advisory Boardno datasin datossin datos

6.2yrs

Permanencia media

62yo

Promedio de edad

Junta con experiencia: La junta directiva de FPH se considera experimentada (6.1 años de antigüedad promedio).